IART MEXC RealStocks
Own real IART shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:29:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Integra LifeSciences Holdings (IART) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $13.86, with a market capitalization of $1.05B and a P/E ratio of 81.01. Over the past 52 weeks, its price has ranged from $8.70 to $20.49. This page covers its latest market performance, valuation, price trends and company information.
$1.05B | |
$13.40 | |
$14.47 | |
$13.40 | |
$13.55 | |
386.12K | |
1.05M | |
81.01 | |
$20.49 | |
$8.70 | |
-- | |
2026-09-30 |
Integra LifeSciences Holdings (IART) last closed at $13.86 as of 2026-11-19 01:00:00, up 2.32% ($0.31) from the previous close of $13.55.
During the latest regular trading session, IART traded between $13.40 and $14.47, with a volume of 386.12K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Integra LifeSciences Holdings (IART) moved from $14.53 to $13.86, representing a decline of 4.58% ($0.67).
The stock traded between $13.40 and $15.07 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.00 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 43.8%
IART is currently trading at $13.86, placing it 43.8% of the way from its 52-week low of $8.70 to its 52-week high of $20.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 4,427 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Integra LifeSciences Holdings (IART) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IART, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IART shares and USD.
IART Shares to USD
1.00 IART shares = 13.864 USD
Calculations are estimates based on the latest available price and are for reference only.